Peptide & Compound Guide
At a glance
| Compound | BPC-157 |
|---|---|
| Type | Synthetic research peptide |
| U.S. regulatory context | Not FDA approved |
| Evidence level | Primarily preclinical; human evidence is limited |
| Research area | Tissue repair, gastrointestinal and musculoskeletal research |
What is BPC-157?
BPC-157 is a synthetic peptide widely discussed online for recovery and tissue-repair claims. The popularity of those claims is much greater than the amount of high-quality human evidence available.
What does the research examine?
Much of the published literature involves animal or laboratory models. Those studies can generate hypotheses but cannot establish clinical efficacy, safe dosing or long-term safety in people.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
FDA has identified safety concerns related to certain compounded substances including BPC-157. It should not be represented as an FDA-approved treatment.
Related: BPC-157 vs. TB-500
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.